Wakefield Asset Management LLLP Has $615,000 Stock Position in Livent Co. (NYSE:LTHM)

Wakefield Asset Management LLLP lowered its stake in shares of Livent Co. (NYSE:LTHMFree Report) by 3.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 33,383 shares of the company’s stock after selling 1,362 shares during the period. Wakefield Asset Management LLLP’s holdings in Livent were worth $615,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in LTHM. Almanack Investment Partners LLC. acquired a new position in Livent during the third quarter worth $35,000. Pinebridge Investments L.P. acquired a new position in Livent during the second quarter worth $45,000. MUFG Americas Holdings Corp acquired a new position in Livent during the third quarter worth $46,000. Credit Agricole S A increased its holdings in Livent by 25.1% during the second quarter. Credit Agricole S A now owns 2,329 shares of the company’s stock worth $64,000 after buying an additional 467 shares during the last quarter. Finally, Harbour Investments Inc. increased its holdings in Livent by 161.8% during the second quarter. Harbour Investments Inc. now owns 2,330 shares of the company’s stock worth $64,000 after buying an additional 1,440 shares during the last quarter. Institutional investors and hedge funds own 96.76% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on LTHM. Mizuho boosted their target price on shares of Livent from $15.00 to $20.00 and gave the stock a “neutral” rating in a report on Thursday, December 28th. TheStreet lowered Livent from a “b-” rating to a “c+” rating in a report on Thursday, November 9th. BMO Capital Markets decreased their target price on Livent from $24.00 to $20.00 and set a “market perform” rating on the stock in a report on Wednesday, November 1st. JPMorgan Chase & Co. decreased their target price on Livent from $25.00 to $15.00 and set a “neutral” rating on the stock in a report on Wednesday, November 29th. Finally, Piper Sandler lowered Livent from a “neutral” rating to an “underweight” rating and decreased their target price for the stock from $18.00 to $15.00 in a report on Tuesday, December 5th. One analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $24.59.

Get Our Latest Report on LTHM

Livent Stock Performance

Shares of NYSE:LTHM opened at $16.51 on Thursday. The company’s 50 day moving average price is $15.53 and its two-hundred day moving average price is $19.03. Livent Co. has a 12-month low of $12.76 and a 12-month high of $29.17. The firm has a market cap of $2.97 billion, a PE ratio of 9.22, a PEG ratio of 0.51 and a beta of 1.76. The company has a quick ratio of 1.99, a current ratio of 3.46 and a debt-to-equity ratio of 0.14.

Livent (NYSE:LTHMGet Free Report) last announced its earnings results on Tuesday, October 31st. The company reported $0.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.02). Livent had a return on equity of 25.60% and a net margin of 40.77%. The business had revenue of $211.40 million for the quarter, compared to analyst estimates of $264.41 million. During the same quarter in the previous year, the company earned $0.41 EPS. The business’s revenue for the quarter was down 8.7% on a year-over-year basis. Equities research analysts predict that Livent Co. will post 1.89 earnings per share for the current year.

Livent Company Profile

(Free Report)

Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications.

Featured Articles

Want to see what other hedge funds are holding LTHM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Livent Co. (NYSE:LTHMFree Report).

Institutional Ownership by Quarter for Livent (NYSE:LTHM)

Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.